Introduction
Materials and methods
General
Automated synthesis
Setup of automated synthesizer
Vial/component | Reagent |
---|---|
CFN-MPS200 | |
18O-water V-vial | Empty |
18O-water recovery vial | Empty |
R1 | 40 mM K2CO3 0.5 mL + 15 mg K.222 in dry 2 mL MeCN |
R2 | 1 mL dry MeCN |
R3 | 20 mg 2-Bromoethyl tosylate in 1 mL o-DCB |
R4 | 1mL water + 1 mL HPLC eluent |
RV1 | Empty |
RV2 | 2 mg MC226 + 3 mg NaH + 0.5 mL DMF |
QMA | Conditioned QMA |
HPLC separation unit | |
HPLC solvent | MeCN/50 mM AcONH4 sol. = 80/20 (500 mL) |
HPLC column | Agilent Eclipse XDB-C18 |
Reservoir | Empty |
Liq. Waste 1 | Empty |
Liq. Waste 2 | Empty |
SPE formulation unit | |
sR1 | 10 mL water for injection |
sR2 | 1.4 mL EtOH |
sR3 | 1 mL ascorbate injection + 100 mL water for injection |
Liq. Waste | Empty |
Formulation vial | 15 mL ascorbate injection/polysorbate 80/Sterile saline = 0.5/0.1/20 |
Product vial | Empty |
tC18 | Conditioned tC18 |
Sterile Filter | 0.22 μm Millex GV |
Process description
Quality control
Acute toxicity
Mutagenicity
Dosimetry
Results
Automated synthesis
QC test | Release criteria* | Run 1 | Run 2 | Run 3 |
---|---|---|---|---|
Visual inspection | Clear, colorless to slightly yellow solution, free of particulate matter | Pass | Pass | Pass |
Radiochemical identity | Retention time of [18F]MC225 peak within ± 10% min compared with the retention time of the known reference MC225 peak | 7.1% | 4.4% | 4.3% |
Radionuclide identity by 511 keV peak | Peak energy of gamma ray spectrum at 511 keV | Pass | Pass | Pass |
Radionuclide identity by half-life determination | 105–115 min | 110 min | 108 min | 115 min |
Content of ethanol | ≤ 10% (v/v) | 7.3% | 6.7% | 6.6% |
Residual acetonitrile | ≤ 410 μg/mL | 36.8 μg/mL | 75.4 μg/mL | 121.7 μg/mL |
Residual dimethylformamide | ≤ 880 μg/mL | N.D. | N.D. | N.D. |
Residual o-dichlorobenzene | ≤ 25 μg/mL | 9.35 μg/mL | 5.41 μg/mL | 3.86 μg/mL |
Content of MC225 | ≤ 10μg/dose | 0.5 μg/dose | 0.6 μg/dose | 0.9 μg/dose |
Total content of MC225 and related impurities | ≤ 10μg/dose | 5.4 μg/dose | 6.2 μg/dose | 3.3 μg/dose |
pH | 6.0 to 8.5 | 6.2 | 6.2 | 6.3 |
Radiochemical purity at release | ≥ 90% | 98.7% | 99.2% | 99.6% |
Molar activity at end of synthesis | N/A | 1613 GBq/μmol | 2002 GBq/μmol | 1112 GBq/μmol |
Residual K.222 | ≤ 40 μg/mL | Pass | Pass | Pass |
Bacterial endotoxins | < 150 EU/vial | < 48.5 EU | < 53.3 EU | < 51.3 EU |
Sterility testing | No growth observed in 14 days | Pass | Pass | Pass |
Filter integrity by bubble point testing | ≥ 40 psi | 48 psi | 44 psi | 44 psi |
Acute toxicity
Mutagenicity
Dosimetry
Injected dose/g tissue (%) * | ||||||
---|---|---|---|---|---|---|
5 min | 15 min | 30 min | 60 min | 180 min | 360 min | |
Blood | 0.70 ± 0.09 | 0.55 ± 0.19 | 0.73 ± 0.13 | 0.87 ± 0.25 | 0.97 ± 0.09 | 0.64 ± 0.04 |
Heart | 2.82 ± 0.32 | 1.54 ± 0.10 | 1.54 ± 0.23 | 1.23 ± 0.29 | 1.28 ± 0.12 | 0.86 ± 0.12 |
Lung | 17.73 ± 5.34 | 7.35 ± 0.49 | 6.17 ± 0.71 | 3.28 ± 0.87 | 1.88 ± 0.12 | 1.11 ± 0.13 |
Liver | 9.74 ± 0.86 | 12.41 ± 0.28 | 11.99 ± 0.19 | 10.01 ± 1.31 | 4.51 ± 0.21 | 2.98 ± 0.51 |
Pancreas | 10.12 ± 0.29 | 15.17 ± 1.32 | 22.85 ± 2.69 | 19.13 ± 3.08 | 37.36 ± 1.87 | 33.34 ± 5.05 |
Spleen | 4.85 ± 0.77 | 4.34 ± 1.04 | 4.83 ± 0.30 | 2.64 ± 0.62 | 2.24 ± 0.39 | 0.94 ± 0.17 |
Kidney | 12.40 ± 1.55 | 9.06 ± 0.50 | 6.88 ± 1.88 | 4.46 ± 0.73 | 2.55 ± 0.78 | 2.35 ± 0.56 |
Stomach | 3.14 ± 0.64 | 3.03 ± 0.18 | 3.66 ± 1.02 | 5.69 ± 1.10 | 3.90 ± 1.35 | 2.69 ± 0.75 |
Small intestine | 3.57 ± 0.24 | 4.13 ± 0.24 | 6.37 ± 0.75 | 9.43 ± 2.22 | 12.40 ± 1.01 | 7.30 ± 0.55 |
Large intestine | 2.19 ± 0.32 | 2.70 ± 0.55 | 2.62 ± 0.15 | 3.52 ± 1.68 | 8.33 ± 3.57 | 13.00 ± 1.50 |
Testis | 0.91 ± 0.28 | 0.87 ± 0.11 | 1.16 ± 0.08 | 1.11 ± 0.31 | 1.76 ± 0.14 | 1.49 ± 0.27 |
Muscle | 1.84 ± 0.30 | 1.26 ± 0.17 | 1.33 ± 0.05 | 1.28 ± 0.43 | 0.80 ± 0.05 | 0.50 ± 0.09 |
Bone | 1.65 ± 0.12 | 1.51 ± 0.16 | 2.16 ± 0.15 | 1.52 ± 0.22 | 2.46 ± 0.17 | 3.38 ± 1.03 |
Brain | 1.24 ± 0.09 | 1.27 ± 0.29 | 1.14 ± 0.04 | 0.93 ± 0.11 | 0.81 ± 0.05 | 0.53 ± 0.05 |
Injected dose/organ (%) * | ||||||
---|---|---|---|---|---|---|
5 min | 15 min | 30 min | 60 min | 180 min | 360 min | |
Heart | 0.44 ± 0.06 | 0.26 ± 0.00 | 0.22 ± 0.01 | 0.22 ± 0.03 | 0.18 ± 0.01 | 0.14 ± 0.01 |
Lung | 3.48 ± 0.93 | 1.61 ± 0.05 | 1.08 ± 0.12 | 0.79 ± 0.06 | 0.35 ± 0.03 | 0.21 ± 0.06 |
Liver | 18.55 ± 1.70 | 24.21 ± 0.86 | 21.31 ± 1.66 | 17.92 ± 1.07 | 7.53 ± 0.57 | 5.18 ± 0.75 |
Pancreas | 2.35 ± 0.27 | 3.10 ± 0.33 | 3.62 ± 0.28 | 4.44 ± 0.88 | 6.37 ± 1.05 | 6.68 ± 1.86 |
Spleen | 0.55 ± 0.12 | 0.48 ± 0.07 | 0.47 ± 0.03 | 0.34 ± 0.08 | 0.17 ± 0.04 | 0.08 ± 0.01 |
Kidney | 7.36 ± 0.70 | 5.36 ± 0.59 | 4.07 ± 0.89 | 2.88 ± 0.34 | 1.47 ± 0.32 | 1.40 ± 0.35 |
Stomach | 2.57 ± 0.41 | 3.36 ± 0.38 | 3.02 ± 0.52 | 3.80 ± 0.61 | 2.60 ± 0.60 | 2.01 ± 0.51 |
Small intestine | 7.20 ± 0.52 | 9.15 ± 0.71 | 12.38 ± 1.57 | 15.76 ± 3.32 | 21.98 ± 4.21 | 14.85 ± 1.62 |
Large intestine | 3.50 ± 0.41 | 4.35 ± 1.10 | 3.58 ± 0.29 | 4.87 ± 1.75 | 9.79 ± 3.34 | 20.19 ± 2.26 |
Testis | 0.20 ± 0.03 | 0.29 ± 0.04 | 0.28 ± 0.03 | 0.33 ± 0.07 | 0.42 ± 0.04 | 0.39 ± 0.09 |
Brain | 0.50 ± 0.05 | 0.54 ± 0.14 | 0.45 ± 0.01 | 0.40 ± 0.06 | 0.31 ± 0.03 | 0.23 ± 0.02 |
Bladder | 0.13 ± 0.08 | 0.12 ± 0.03 | 0.06 ± 0.02 | 0.26 ± 0.15 | 0.12 ± 0.10 | 0.38 ± 0.20 |
Urine | 0.10 ± 0.01 | 0.43 ± 0.19 | 1.34 ± 0.25 | 2.88 ± 0.88 | 11.35 ± 0.57 | 17.26 ± 2.26 |
Bladder + urine | 0.24 ± 0.07 | 0.56 ± 0.16 | 1.40 ± 0.26 | 3.13 ± 0.97 | 11.48 ± 0.60 | 17.64 ± 2.11 |
Target organ | Absorbed dose (μGy/MBq) | |
---|---|---|
With urination* | Without urination | |
Adrenals | 12.9 | 12.9 |
Brain | 5.0 | 5.0 |
Breasts | 7.8 | 7.8 |
Gallbladder | 16.0 | 16.1 |
Lower large intestine wall | 28.9 | 29.7 |
Small intestine | 36.0 | 36.3 |
Stomach wall | 19.5 | 19.5 |
Upper large intestine wall | 30.4 | 30.6 |
Heart wall | 10.3 | 10.3 |
Kidneys | 18.0 | 18.1 |
Liver | 26.9 | 26.9 |
Lungs | 13.4 | 13.4 |
Muscle | 10.2 | 10.4 |
Ovaries | 15.5 | 16.2 |
Pancreas | 63.8 | 63.9 |
Red marrow | 12.0 | 12.2 |
Osteogenic cells | 14.8 | 14.9 |
Skin | 7.1 | 7.1 |
Spleen | 13.9 | 13.9 |
Testes | 8.5 | 9.0 |
Thymus | 9.3 | 9.3 |
Thyroid | 9.2 | 9.2 |
Urinary bladder wall | 32.5 | 59.6 |
Uterus | 15.3 | 17.0 |
Total body | 11.9 | 12.1 |
Effective dose (μSv/MBq) | 15.7 | 16.9 |